Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
The European Partnership for Personalised Medicine has just launched a new opportunity for start-ups, researchers and early-stage teams working on cutting-edge solutions in personalised medicine.
Translating breakthrough innovations in personalised medicine (PM) into commercialised solutions that directly benefit patients remains a critical challenge in the healthcare industry. The absence of tailored business support often hinders the translation of scientific advancements & discoveries into market-ready solutions.
The EP PerMed Venture Creation Programme offers guidance from experienced mentors, ensuring that each project receives support throughout its journey. In this webinar, EP PerMed will provide an overview of the programme, including its requirements, the application process, and the support available, offering key insights for those interested in applying.
More information and registration here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Marie SkÅ‚odowska-Curie Action (MSCA) European Innovative Training Network “PBNv2 - Next generation Pass-By Noise approaches for new powertrain vehicles” started in May 2017. Their research has the shared objective of investigating the possibilities to decrease pass-by noise of vehicles.
The project is a collaboration between 17 research institutions and companies in the European automotive R&D and provides a learning environment for 14 PhD fellows. The Belgian partner is the Noise and Vibration Research Group of KU Leuven, and this project is one of the many Horizon 2020 MSCA Innovative Training Networks that the KU Leuven research group participates in.